Overview

A Study To Assess Absorption Of Study Drug Dacomitinib (PF-00299804), Given As An Oral Tablet Compared To An Intravenous Infusion In Healthy Volunteers

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the proportion of study drug dacomitinib or PF-00299804, that is taken up from the digestive tract into the body when given as an oral tablet compared with that taken up by an intravenous dose.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer